IVA TIRRES: Open Payments
NPI 1558972752 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,004 in 57 payments from 17 companies in 2025. Trend: 2023 $1,990 · 2024 $1,521 · 2025 $1,004
Food & beverage: $1,004
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $163 |
| RECORDATI_RARE_DISEASES_INC. | 6 | $143 |
| ABBVIE INC. | 4 | $87 |
| Lilly USA, LLC | 4 | $73 |
| Xeris Pharmaceuticals, Inc. | 3 | $67 |
| Tandem Diabetes Care, Inc. | 3 | $64 |
| Corcept Therapeutics | 2 | $62 |
| Mannkind Corporation | 3 | $61 |
| Sequel Med Tech, LLC | 2 | $53 |
| Abbott Laboratories | 2 | $47 |
Products named: ISTURISA, Ozempic, JARDIANCE, SYNTHROID, t:slim X2 Insulin Pump with Control-IQ, Korlym, AFREZZA, TWIIST.
Industry payments across AZ — which companies pay providers there.
